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Correction to: EMBO Mol Med (2013) 5: 280–293. DOI 10.1002/emmm.201201739
In the above article, holo-cytochrome c-type synthase was used
instead of holocytochrome c-type synthase, the official gene name.
This error occurs in three places in the text and the correct sentences
should read:
In the abstract:
Now we provide the evidence that non-canonical mitochondrial-
dependent apoptosis explains the phenotype of microphthalmia
with linear skin lesions (MLS), an X-linked developmental disorder
caused by mutations in the holocytochrome c-type synthase (HCCS)
gene.
In the introduction:
HCCS is a highly conserved gene from fungi to metazoans and
encodes a mitochondrial holocytochrome c (Cytc)-type synthase,
also known as ‘heme lyase’, located on the outer surface of the inner
mitochondrial membrane (Schaefer et al, 1996; Schwarz & Cox,
2002).
In ‘The paper explained’ section:
We demonstrate that inactivation of holocytochrome c-type
synthase (HCCS), a transcript important for the mitochondrial respi-
ratory chain (MRC), is associated with unconventional activation of
caspase-9 in the mitochondria triggered by MRC impairment and
overproduction of reactive oxygen species.
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